Insight Molecular Diagnostics Inc. (IMDX)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) 
$
3. 01
-0.05
-1.634%
$
- Market Cap
- P/E Ratio
- Div Yield
181,500 Volume
- Eps
$ 3.06
Previous Close 
Want to track IMDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Insight Molecular Diagnostics Inc. (IMDX) Statistics
Valuation metrics
Market Cap -
Enterprise value 93.69M
Trailing P/E (ttm) -2.22
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) 65.16
Price/Book (mrq) -5.81
Enterprise Value/Revenue 56.1
Enterprise Value/EBITDA -2
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 156.4K
Average volume (90 days) 171.09K
Price summary
52-Week low 2.42
52-Week high 8.51
Beta -
50-Day moving average 3.77
200-Day moving average 4.36
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 25 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -29.56%
Operating margin -25.59%
Operational effectiveness
Return on assets -1.68%
Return on equity 2.72%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.34
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.48
Total debt (mrq) -
Total Debt/Equity (mrq) -0.12
Current ratio (mrq) 2%
Book value per share (mrq) -0.58
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
